Jin-an Jiao - Jul 19, 2021 Form 3 Insider Report for HCW Biologics Inc. (HCWB)

Role
VP of Development
Signature
/s/ Hing C. Wong, as Attorney-in-Fact for Jin-an Jiao
Stock symbol
HCWB
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
3
Date filed
7/19/2021, 04:58 PM
Next filing
Sep 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCWB Common Stock 20.6K Jul 19, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCWB Stock Option (Right to Buy) Jul 19, 2021 Common Stock 30.9K $0.14 Direct F1
holding HCWB Stock Option (Right to Buy) Jul 19, 2021 Common Stock 8.57K $0.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These option shares were part of a stock option grant covering 51,428 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023.
F2 20% of the total shares subject to the stock option grant will vest on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024.

Remarks:

Exhibit 24.1: Power of Attorney